| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 2 | 3 | $72,487.60 | 88,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 2 | 3 | $72,487.60 | 88,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 2 | 3 | $72,487.60 | 88,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 2 | 3 | $72,487.60 | 88,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 2 | 3 | $72,487.60 | 88,000 | 1:22.38 |
| Sells | 2 | 7 | $1,622,534.32 | 517,889 | ||
See activity going back 12 months โ create a free account | ||||||
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Puhlmann Markus Chief Medical Officer | Purchase | 6,000 | $0.83 | $4,980.00 | View Details |
| Nov 12, 2026 | Puhlmann Markus Chief Medical Officer | Purchase | 35,000 | $0.84 | $29,564.50 | View Details |
| Nov 11, 2026 | Spoor Johan M. Director | Purchase | 47,000 | $0.81 | $37,943.10 | View Details |
| Sep 3, 2026 | Lantheus Alpha Therapy, LLC 10% Owner | Sale | 80,783 | $3.11 | $250,895.84 | View Details |
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC 10% Owner | Sale | 167,149 | $3.15 | $526,051.33 | View Details |
| Sep 2, 2026 | Lantheus Alpha Therapy, LLC 10% Owner | Sale | 42,129 | $3.11 | $131,219.20 | View Details |
| Sep 1, 2026 | Lantheus Alpha Therapy, LLC 10% Owner | Sale | 35,769 | $3.12 | $111,574.24 | View Details |
| Aug 31, 2026 | Lantheus Alpha Therapy, LLC 10% Owner | Sale | 78,145 | $3.14 | $245,609.73 | View Details |
| Sep 1, 2026 | Lantheus Holdings, Inc. 10% Owner | Sale | 35,769 | $3.12 | $111,574.24 | View Details |
| Aug 31, 2026 | Lantheus Holdings, Inc. 10% Owner | Sale | 78,145 | $3.14 | $245,609.73 | View Details |